Global 3d Bioprinting Market Bwc20126

Global 3D Bioprinting Market Size By Component (Micro extrusion, Inkjet, Laser), By Material (Hydrogel, Living Cells), By Application (Skin, Drug Research), End-User (Biopharma, Academia), Region (North America, Europe, Asia-Pacific and LAMEA); Trend Analysis, Market Competition Scenario & Outlook, 2020-2026.

  • Published Date: August 2020
  • Report ID: BWC20126
  • Available Format: PDF
  • Page: 175

Report Overview

Global 3D Bioprinting Market size- Industry Trends & Outlook Report 2026


Global 3D Bioprinting Market Overview


3D Bioprinting is an application of 3D printers in the medical field and involves 3D printing of natural tissues and organs by layering living cells. Its process passes through three stages viz., pre-bioprinting, bioprinting, and post-bioprinting. The output construct of the 3D Bioprinting is also preserved for R & D purposes. It is used to develop natural look-alike organ and tissue constructs which are again used for drug screening, tissue engineering & regenerative medicine, and tissue transplantation. The enterprises use innovative approaches and a combination of new materials for 3D printing. They engage in alliances, agreements, and collaborations with diverse market players besides product innovation and approvals to maintain or grow their share in the market.


Global 3D Bioprinting Market Outlook and Trends


Growth drivers 


Demand for High Throughput Models of Tissue


The drug research and development processes need high throughput models of tissue, and it leads to more demand for 3D Bioprinting for assuring effective regenerative medication. It assists in testing the efficacy of the drugs under study so that they closely imitate the native tissue. Due to its high utility in drug development and tissue implantation, the 3D Bioprinting Market holds bright prospects for the future.


Technological Advancements


3D Bioprinting technology has found increasing acceptance in the medical field. It has changed the diagnosis and treatment of various physical conditions through the fabrication of artificial tissues and organs. Bioprinting companies continuously work on the advanced application of 3D Bioprinting in drug development, tissue transplantation, and regenerative medicine for ensuring customized medical treatment, better patient care, and as a substitute to organ transplantation. Significant technological advancements have been noticed for skin tissue development, cancer therapeutics, liver modeling, and bone, and cartilage development. They provide an edge to the market player, securing its market share.




Shortage of Skilled Professionals


The Global 3D Bioprinting market holds tremendous potential in the medical field, but its growth is restrained by the scarcity of skilled professionals to operate technologically advanced 3D Bioprinters. To build such capability poses a challenge to this market.


Market Segmentation


The Global 3D Bioprinting market is segmented into three categories based on Component, Material and Application. Component-based segments include Micro Extrusion, Inkjet and Laser; while Material based segments include Hydrogel and Living Cells. The Application based segment is again divided into Skin and Drug Research.


In Material-based segment, Living cells segment accounts for the largest share in the market due to its extensive use in regenerative medicines and stem cells research and increased funding support. It is expected to continue its dominance during the projected period also. In the Application based segment, skin bio printing segment dominates the market in comparison to others, and it is likely to register the highest CAGR during the forecast period.

Regional Insights 

North America retained the largest share in the market in 2019 due to growing state expenditure on health care, technological developments and robust healthcare infrastructure. It is anticipated to maintain its share and momentum in the market during the forecast period. However, Asia Pacific Market is expected to grow at the highest CAGR during this period due to increasing R & D activities including stem cell research, growing need for organ transplants and increasing initiatives by market players. China and India offer tremendous growth opportunities for this market because of growing state support, rise in cosmetic surgeries, liberal regulations and little data requirement.


Competitive landscape


The major players in the market are EnvisionTEC (Germany), Organovo Holdings Inc. (US), Cyfuse Biomedical KK (Japan), BioBot (US), Nano3D Biosciences, Inc.(US), Aspect Biosystems Ltd.(Canada), 3Dynamic Systems Ltd (US), CELLINK (US), Materialise NV (UK), Vivax Bio, LLC (US) and others. 

Recent Developments


February 12, 2020: Researchers at Northwestern University prints tissues that mimic human bile duct by using EnvisionTEC 3D Bio-Plotter. Bile duct plays a vital role in digestion, and its cancer leaves fewer survival chances.


October 23, 2019: Cyfuse Biomedical KK announces business alliance with Marubeni Corporation regarding Global Expansion of a new Bio 3D Printer S-PIKE developed and commercialized by Cyfuse.


Scope of the Report




Years Considered

Historical data – 2016-2019

Base Year – 2019

Forecast – 2020 – 2026

Facts Covered

Revenue in USD Million

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, South Korea UAE, South Africa, Saudi Arabia.

Product/Service Segmentation

By Component, By Material, By Application, By End-user

Key Players

EnvisionTEC (Germany), Organovo Holdings Inc. (US), Cyfuse Biomedical KK (Japan), BioBot (US), Nano3D Biosciences, Inc.(US), Aspect Biosystems Ltd.(Canada), 3Dynamic Systems Ltd (US), CELLINK (US), Materialise NV (UK), Vivax Bio, LLC (US).

By Component

Ø  Micro extrusion

Ø  Inkjet

Ø  Laser  

By Material

Ø  Hydrogel

Ø  Living Cells  

By Application

Ø  Skin

Ø  Drug Research

By End-User

Ø  Biopharma

Ø  Academia

By Region:

Ø  North America

Ø  Europe

Ø  Asia Pacific

Ø  Latin America

Ø  Middle East & Africa


The objective of the Study:

Ø  To analyze and estimate the Global 3D Bioprinting Market size, in terms of value.

Ø  To examine the market segmentation carefully and estimate the market size, in terms of value, based on the region by segmenting the Global 3D Bioprinting Market into five regions, namely, North America, Europe, Asia Pacific, Rest of the World and their leading countries.

Ø  To outline, categorize, and project the Global 3D Bioprinting Market based on the Type, Application, End-User, and Region.

Ø  To examine competitive developments in applications, technology, and network, content, and live streaming within the Global 3D Bioprinting Market.

Ø  To highlight market dynamics such as drivers, restraints, opportunities, and challenges and their impact.

Ø  To provide a detailed competitive landscape, including major players, their strategic profiles, and market shares.


Business Questions Answered by the Report:


Ø  How will the market drivers, restraints, and opportunities affect the market dynamics?

Ø  What will be the market size in terms of value and volume and market statistics with a detailed classification?

Ø  Which segment dominates the market or region, and which one will be the fastest-growing, and why?

Ø  Who are the key players in the market, and what is their share?

Ø  What is the strategy adopted by key players, and how does it affect the existing and new players?


Customization Scope for the Client:


Client satisfaction is our first and last priority, and that is why BlueWeave Consulting offers customization as per client’s specific needs. The following customization options are available for the report:

Ø  Additional Company Information

Ø  Detail Analysis of five additional companies

Ø  Additional country analysis

Ø  Detailed segment analysis